Lymphatic spread is an important prognostic factor in gastric cancer. The TNM classification requires at least 15 lymph nodes to stage and identify three prognostic groups according to the number of metastatic lymph nodes: N1 (1-6), N2 (7-15), N3 (>15). The aim of this study was to investigate which type of lymph node dissection allows an accurate staging.
Methods
From 1996 to 2001, we treated 140 gastric cancer patients, 27 with D1 and 113 with D2 dissection. We evaluated lymph node count, status and ratio between metastatic and total number of excised lymph nodes, keeping 20% as the cutoff value.
Results
The mean number of lymph nodes was 18 and 33 respectively for D1 and D2 (P <0.001), 41% of patients in D1 and 5% in D2 had less than 15 lymph nodes (P <0.001). 59% in D1 and 73% in D2 (P = 0.145) had lymph node metastases, but this incidence decreased to 36% (P = 0.045) and 16% (P <0.001) respectively for D, and D2 when less than 15 lymph nodes were available. Considering the ratio between metastatic and total number of lymph nodes, 45% of D1 versus 3% of D2 (P <0.001) in the N1 group exceeded 20%.
Conclusions
D2 lymph node dissection is better than D1 in providing at least 15 lymph nodes required for a correct staging. We confirm the risk of a downstage when less than 15 lymph nodes are available.
DentD.M., MaddenM.V., PriceS.K.: Randomized comparison of R1 and R2 gastrectomy for gastric cancer.Br J Surg, 75: 110–112, 1988.
2.
WaneboH.J., KennedyB.J., WinchesterD.P., FremgenA., StewartA.K.: Gastric carcinoma: does lymph node dissection alter survival?J Am Coll Surg, 183: 616–624, 1996.
3.
SiewertJ.R., BöttcherK., SteinH.J., RoderJ.D. and the German Gastric Carcinoma Group: Relevant prognostic factors in gastric cancer – ten year results of the German Gastric Cancer Study.Ann Surg, 228: 449–461, 1998.
4.
BonenkampJ.J., HermansJ., SasakoM., Van De VeldeC.J.H. for the Dutch Gastric Cancer Group: Extended lymph-node dissection for gastric cancer.N Engl J Med, 340: 908–914, 1999.
5.
CuschieriA., WeedenC., FieldingJ., BancewiczJ., CravenJ., JoypaulV., SydesM., FayersP.: Surgical Co-operative Group: Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial.Br J Cancer, 79: 1522–1530, 1999.
6.
PacelliF., DogliettoG.B., BellantoneR., AlfieriS., SgadariA., CrucittiF.: Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients.B J Surg, 80: 1153–1156, 1993.
7.
RobertsonC.S., ChungS.C.S., WoodsS.D., GriffinS.M., RaimesS.A., LauJ.T., LiA.K.: A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer.Ann Surg, 220: 176–182, 1994.
8.
IkeguchiM., OkaS.I., GomyoY., TsujitaniS.I., MaetaM., KaibaraN.: Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.Anticancer Res, 20: 1285–1290, 2000.
9.
VolpeC.M., DriscollD.L., DouglassHOJr.: Outcome of patient with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.Ann Surg Oncol, 7: 139–144, 2000.
10.
De ManzoniG., VerlatoG., GuglielmiA., LaterzaE., GennaM., CordianoC.: Prognostic significance of lymph node dissection in gastric cancer.Br J Surg, 83: 1604–1607, 1996.
11.
KarpehM.S., LeonL., KlimstraD., BrennanM.F.: Lymph node staging in gastric cancer: is location more important than number?Ann Surg, 232: 362–371, 2000.
12.
LeeH.K., YangH.K., KimW.H., LeeK.U., ChoeK.J., KimJ.P.: Influence of the number of lymph nodes examined on staging of gastric cancer.Br J Surg, 88: 1408–1412, 2001.
13.
SobinL.H., WittekindC.H.: TNM Classification of Malignant Tumours.International Union Against Cancer, 5th edition.John Wiley, New York, 1997.
14.
FlemingI.D., CooperJ.S., HensonD.E., HutterR.V.P., KennedyB.J., MurphyG.P.: Manual for staging of cancer.American Joint Committee on Cancer, 5th edn, Lippincott, Philadelphia, 1997.
15.
IchikuraT., TomimatsuS., UefujiK., KimuraM., UchidaT., MoritaD., MochizukiH.: Evaluation of the new American Joint Committee on Cancer/International Union against Cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification.Cancer, 86: 553–558, 1999.
16.
KenyukaiI.: Japanese classification of gastric carcinoma.Japanese Research Society for Gastric Cancer. First English Edition. Kanehara & Co, Tokyo, 1995.
17.
CandelaF.C., UrmacherC., BrennanM.F.: Comparison of the conventional method of lymph node staging with a comprehensive fat-clearing method for gastric adenocarcinoma.Cancer, 66: 1828–1832, 1990.
18.
FeinsteinA.R., SosinD.M., WellsC.K.: The Will Rogers phenomenon.Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med, 312: 1604–1608, 1985.
19.
KoderaY., YamamuraY., ShimizuY., ToriiA., HiraiT., YasuiK., MorimotoT., KatoT., KitoT.: Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification?J Surg Oncol, 69: 15–20, 1998.
20.
InoueK., NakaneY., IiyamaH., SatoM., KanbaraT., NakaiK., OkumuraS., YamamichiK., HiokiK.: The superiority of ratiobased lymph node staging in gastric carcinoma.Ann Surg Oncol, 9: 27–34, 2002.
21.
OkamuraT., TsujitaniS., KorenagaD., HaraguchiM., BabaH., HiramotoY., SugimachiK.: Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis.Am J Surg, 155: 476–480, 1988.
22.
Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma, 2nd English edn, Gastric Cancer1: 10–14, 1998.
23.
Sasako M, Dutch Gastric Cancer Study Group: Risk factors for surgical treatment in Dutch gastric cancer trial.Br J Surg, 84: 1567–1571, 1997.
24.
MaruyamaK., SasakoM., KinoshitaT., SanoT., KataiH., OkajimaK.: Pancreas-preserving total gastrectomy for proximal gastric cancer.World J Surg, 19: 532–536, 1995.
25.
DogliettoG.B., PacelliF., CaprineP., BossolaM., Di StasiC.: Pancreas-preserving total gastrectomy for gastric cancer.Arch Surg, 135: 89–92, 2000.
26.
OtsujiE., YamaguchiT., SawaiK., OkamatoT., TakahashiT.: End results of simultaneous pancreatectomy, splenectomy and total gastrectomy for patients with gastric carcinoma.Br J Cancer, 75: 1219–1223, 1997.
27.
NoguchiY., ImadaT., MatsumotoA., CoitD.G., BrennanM.F.: Radical surgery for gastric cancer, a review of the Japanese experience.Cancer, 64: 2053–2062, 1989.
28.
AdachiY., OshiroT., OkuyamaT., KamakuraT., MoriM., MaeharaY., SugimachiK.: A simple classification of lymph node level in gastric carcinoma.Am J Surg, 169: 382–385, 1995.
29.
WagnerP.K., RamaswamyA., RuschoffJ., Schmitz-MoormannP., RothMundM.: Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer.Br J Surg, 78: 825–827, 1991.
30.
DharD.K., KubotaH., TachibanaM., KotohT., TabaraH., MasunagaR., KohnoH., NagasueN.: Body mass index determines the success of lymph node dissection and predicts outcome of gastric carcinoma patients.Oncology, 59: 18–23, 2000.
31.
De ManzoniG., VerlatoG., MorgagniP., RovielloF., TomezzoliA., Di LeoA., SaragoniL., MarrelliD., KuriharaA.: The number of positive nodes is directly related to the number of excised nodes, particularly in advanced gastric cancer. Results of an Italian research group for gastric cancer (IRGGC). In: Proceedings of 4th International Gastric Cancer Congress 2001, April 30-May 2, New York, BrennanM.F., KarpehM.S. (Eds), pp 1023–1026, Monduzzi, Bologna, 2001.
32.
SogaJ., OhyamaS., MiyashitaK., SuzukiT., NashimotoA., TanakaO., SasakiK., MutoT.: A statistical evaluation of advancement in gastric cancer surgery with special reference to the significance of lymphadenectomy for cure.World J Surg, 12: 398–405, 1988.
33.
IchikuraT., TomimatsuS., OkusaY., UefujiK., TamakumaS.: Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer.J Clin Oncol, 11: 1894–1900, 1993.
34.
SiewertJ.R., KestelmeierR., BuschR., BöttcherK., RoderJ.D., MullerJ., FellbaumC., HoflerH.: Benefit of lymph node dissection for patients with gastric cancer and pNO and pN1 lymph node metastasis.Br J Surg, 83: 1144–1147, 1996.
35.
DegiuliM., SasakoM., PontiA., SoldatiT., DaneseF., CalvoF.: Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group.Prospective multicenter surgical study. Clin Oncol, 16: 1490–1493, 1998.
36.
KassabP., CastroO., IliasE., NigroS.P., SafatleN.F.: Lymph node patterns after radical D2 dissection for gastric cancer. In: Proceedings of 4th International Gastric Cancer Congress, 2001 April 30-May 2, New York, BrennanM.F., KarpehM.S. (Eds), pp 873–875, Monduzzi, Bologna, 2001.
37.
HundalS.A., PhillipsJ.L., MenckH.R.: The national cancer data base report on poor survival of U.S.gastric carcinoma patients treated with gastrectomy. Fifth edition American Joint Committee on Cancer Staging, proximal disease, and the “different disease” hypopthesis. Cancer, 88: 921–932, 2000.
38.
NodaN., SasakoM., YamaguchiN., NakanishiY.: Ignoring small lymph nodes can be a major cause of staging error in gastric cancer.Br J Surg, 85: 831–834, 1998.
